Pharma Journalist -

Thermo Fisher Scientific and Patheon together announced that their boards of directors have approved Thermo Fisher's acquisition of Patheon at a price of $7.2 billion. Thermo Fisher…
Read More...

Upon the approval from the FDA to sell vadadustat to Fresenius Medical Care dialysis clinics in the US, Akebia Therapeutics and Vifor Pharma Group entered into an exclusive license…
Read More...

Patheon announced that with an investment of $26 million it has updated sterile Pharmaceutical Development Services (PDS) suites at its Greenville, NC manufacturing site. The PDS Suites…
Read More...

DelMar Pharmaceuticals  announced that it has signed collaboration agreement with PRA Health Sciences for company's Phase 3 trial of VAL-083 in recurrent glioblastoma multiforme (GBM).…
Read More...

Jose Carmona (Pepe) has been appointed as CFO of Radius health. He will succeed to Nick Harvey, who will continue as an advisor to the Company in the areas of Finance, Business…
Read More...

Biogen has acquired Remedy Pharmaceuticals’ Phase 3 candidate CIRARA (intravenous glyburide). The target indication for CIRARA is large hemispheric infarction (LHI), a severe form of…
Read More...

Siemens Healthineers announced its strategic partnership with Imricor medical system to develop an integrated solution that combines the clinical benefits of real-time MRI scans with…
Read More...

Pfizer announced that its 13-valent Pneumococcal Conjugate (PCV13) Vaccine has been selected for immunization program of India’s babies in select states. Results of the…
Read More...

Merck announced its collaboration with Stelis Biopharma to open its first joint Process Scale-Up Lab at the Stelis Biopharma R&D Facility in the Jigani industrial estate, Bangalore.…
Read More...

FDA announced the authorization of Flourish Pediatric Esophageal Atresia Anastomosis to treat esophageal atresia in Infants. Flourish Pediatric Esophageal Atresia Anastomosis is a…
Read More...